---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-016075"
form_type: "8-K"
ticker: "RNGE"
cik: "0001438943"
company_name: "RANGE IMPACT, INC."
filed_at: "2024-04-26T23:59:59+00:00"
generated_at: "2026-06-03T06:22:56.718312+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Range Impact promotes Patricia Missal to CFO, plans divestiture of Graphium subsidiary

## Summary
- Patricia Missal promoted from Controller to CFO, replacing Richard McKilligan, effective April 25, 2024.
- Missal receives annual base salary of $225,000 and options to purchase 250,000 shares with vesting terms.
- Dr. Brandon Zipp and Richard McKilligan transition to Graphium Biosciences roles for proposed divestiture.
- Range Impact engaged First Liberties Financial in Dec. 2023 to help raise capital for Graphium divestiture.

## SEC filing metadata
- accession: 0001493152-24-016075
- form_type: 8-K
- ticker: RNGE
- cik: 0001438943
- company_name: RANGE IMPACT, INC.
- filed_at: 2024-04-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438943/000149315224016075/0001493152-24-016075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438943/000149315224016075/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-016075
- JSON: https://secwatch.observer/filing/0001493152-24-016075.json
- Plain text: https://secwatch.observer/filing/0001493152-24-016075.txt

## Key facts
- Executive change
  Richard McKilligan changed role as Chief Financial Officer of Graphium Biosciences, Inc. at RANGE IMPACT, INC..
  - Action: will remain as
  - Role: Chief Financial Officer of Graphium Biosciences, Inc.
  source text: Mr. McKilligan will remain as Chief Financial Officer of Graphium Biosciences, Inc., a wholly-owned subsidiary of the Company (“Graphium”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438943/000149315224016075/0001493152-24-016075-index.htm
- Executive change
  Patricia Missal was elected as Chief Financial Officer at RANGE IMPACT, INC..
  - Action: elected
  - Role: Chief Financial Officer
  source text: On April 25, 2024, the Board of Directors of Range Impact, Inc. (the “Company”) elected Patricia Missal as Chief Financial Officer, replacing Richard McKilligan who had previously served as the Company’s Chief Financial Officer, Counsel and Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438943/000149315224016075/0001493152-24-016075-index.htm
- Executive change
  Dr. Brandon Zipp changed role as Chief Science Officer of Graphium at RANGE IMPACT, INC..
  - Action: serve exclusively as
  - Role: Chief Science Officer of Graphium
  source text: Dr. Brandon Zipp, who had served as the Company’s Chief Science Officer, will, effective April 25, 2024, serve exclusively as the Chief Science Officer of Graphium.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438943/000149315224016075/0001493152-24-016075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.